Know Cancer

or
forgot password
  • cancer clinical trials in bozeman, MT

  • Fulvestrant With or Without Lapatinib in Treating Postmenopausal Women With Stage III or Stage IV Breast Cancer That is Hormone Receptor-Positive
    Bozeman Deaconess Hospital

    Trial Locations
    Bozeman Deaconess Hospital
    Bozeman Deaconess Cancer Center
    Recurrent Breast Cancer, Stage IIIB Breast Cancer, Stage IIIC Breast Cancer, Stage IV Breast Cancer
    Doxorubicin, Cyclophosphamide, and Paclitaxel With or Without Bevacizumab in Treating Patients With Lymph Node-Positive or High-Risk, Lymph Node-Negative Breast Cancer
    Bozeman Deaconess Hospital

    Trial Locations
    Bozeman Deaconess Hospital
    Bozeman Deaconess Cancer Center
    Male Breast Cancer, Stage IA Breast Cancer, Stage IB Breast Cancer, Stage II Breast Cancer, Stage IIIA Breast Cancer, Stage IIIB Breast Cancer
    Gemcitabine After Surgery in Treating Patients With Newly Diagnosed or Recurrent Bladder Cancer
    Bozeman Deaconess Cancer Center
    Bozeman, Montana 59715
    Bladder Cancer
    Duloxetine in Treating Peripheral Neuropathy Caused by Chemotherapy in Patients With Cancer
    Bozeman Deaconess Cancer Center
    Bozeman, Montana 59715
    Neurotoxicity Syndromes, Pain, Peripheral Neuropathy, Unspecified Adult Solid Tumor, Protocol Specific
    Irinotecan and Cetuximab With or Without Bevacizumab in Treating Patients With Metastatic Colorectal Cancer That Progressed During First-Line Therapy
    Bozeman Deaconess Hospital

    Trial Locations
    Bozeman Deaconess Hospital
    Bozeman Deaconess Cancer Center
    Recurrent Colon Cancer, Recurrent Rectal Cancer, Stage IVA Colon Cancer, Stage IVA Rectal Cancer, Stage IVB Colon Cancer, Stage IVB Rectal Cancer
    First-Line Chemotherapy and Trastuzumab With or Without Bevacizumab in Treating Patients With Metastatic Breast Cancer That Overexpresses HER-2/NEU
    Bozeman Deaconess Hospital

    Trial Locations
    Bozeman Deaconess Hospital
    Bozeman Deaconess Cancer Center
    HER2-positive Breast Cancer, Male Breast Cancer, Recurrent Breast Cancer, Stage IV Breast Cancer
    Everolimus, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma
    Bozeman Deaconess Cancer Center
    Bozeman, Montana 59715
    Brain and Central Nervous System Tumors
    Octreotide Acetate and Recombinant Interferon Alfa-2b or Bevacizumab in Treating Patients With Metastatic or Locally Advanced, High-Risk Neuroendocrine Tumor
    Bozeman Deaconess Hospital

    Trial Locations
    Bozeman Deaconess Hospital
    Bozeman Deaconess Cancer Center
    Neuroendocrine Carcinoma
    Tamoxifen Citrate or Letrozole With or Without Bevacizumab in Treating Women With Stage III or Stage IV Breast Cancer
    Bozeman Deaconess Hospital

    Trial Locations
    Bozeman Deaconess Hospital
    Bozeman Deaconess Cancer Center
    Recurrent Breast Cancer, Stage IIIB Breast Cancer, Stage IV Breast Cancer
    Melphalan, Prednisone, and Thalidomide or Lenalidomide in Treating Patients With Newly Diagnosed Multiple Myeloma
    Bozeman Deaconess Cancer Center
    Bozeman, Montana 59715
    Stage I Multiple Myeloma, Stage II Multiple Myeloma, Stage III Multiple Myeloma
    Gemcitabine Hydrochloride and Erlotinib Hydrochloride With or Without Monoclonal Antibody Therapy in Treating Patients With Metastatic Pancreatic Cancer That Cannot Be Removed By Surgery
    Bozeman Deaconess Hospital

    Trial Locations
    Bozeman Deaconess Hospital
    Bozeman Deaconess Cancer Center
    Stage IV Pancreatic Cancer
    Azacitidine and Gemtuzumab Ozogamicin in Treating Older Patients With Previously Untreated Acute Myeloid Leukemia
    Bozeman Deaconess Hospital

    Trial Locations
    Bozeman Deaconess Hospital
    Bozeman Deaconess Cancer Center
    Adult Acute Megakaryoblastic Leukemia (M7), Adult Acute Monoblastic Leukemia (M5a), Adult Acute Monocytic Leukemia (M5b), Adult Acute Myeloblastic Leukemia With Maturation (M2), Adult Acute Myeloblastic Leukemia Without Maturation (M1), Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Inv(16)(p13;q22), Adult Acute Myeloid Leukemia With t(16;16)(p13;q22), Adult Acute Myeloid Leukemia With t(8;21)(q22;q22), Adult Acute Myelomonocytic Leukemia (M4), Adult Erythroleukemia (M6a), Adult Pure Erythroid Leukemia (M6b), Secondary Acute Myeloid Leukemia, Untreated Adult Acute Myeloid Leukemia
    Capecitabine and Lapatinib With or Without Cixutumumab in Treating Patients With Previously Treated HER2-Positive Stage IIIB, Stage IIIC, or Stage IV Breast Cancer
    Bozeman Deaconess Hospital

    Trial Locations
    Bozeman Deaconess Hospital
    Bozeman Deaconess Cancer Center
    HER2-positive Breast Cancer, Male Breast Cancer, Recurrent Breast Cancer, Stage IIIB Breast Cancer, Stage IIIC Breast Cancer, Stage IV Breast Cancer
    American Ginseng in Treating Patients With Fatigue Caused by Cancer
    Bozeman Deaconess Cancer Center
    Bozeman, Montana 59715
    Chronic Myeloproliferative Disorders, Fatigue, Leukemia, Lymphoma, Lymphoproliferative Disorder, Multiple Myeloma and Plasma Cell Neoplasm, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Neoplasms, Precancerous Condition, Unspecified Adult Solid Tumor, Protocol Specific
    Paclitaxel Albumin-Stabilized Nanoparticle Formulation and Bevacizumab Followed By Bevacizumab and Erlotinib Hydrochloride in Treating Patients With Metastatic Breast Cancer
    Bozeman Deaconess Hospital
    Bozeman, Montana 59715
    Estrogen Receptor-negative Breast Cancer, HER2-negative Breast Cancer, Progesterone Receptor-negative Breast Cancer, Stage IV Breast Cancer, Triple-negative Breast Cancer
    Pemetrexed or Erlotinib as Second-Line Therapy in Treating Patients With Advanced Non-Small Cell Lung Cancer
    Bozeman Deaconess Hospital

    Trial Locations
    Bozeman Deaconess Hospital
    Bozeman Deaconess Cancer Center
    Recurrent Non-small Cell Lung Cancer, Stage IIIA Non-small Cell Lung Cancer, Stage IIIB Non-small Cell Lung Cancer, Stage IV Non-small Cell Lung Cancer
    S0715: Acetyl-L-Carnitine in Preventing Neuropathy in Women With Stage I, Stage II, or Stage IIIA Breast Cancer Undergoing Chemotherapy
    Bozeman Deaconess Cancer Center
    Bozeman, Montana 59715
    Breast Cancer, Chemotherapeutic Agent Toxicity, Fatigue, Neuropathy, Neurotoxicity
    Paclitaxel, Paclitaxel Albumin-Stabilized Nanoparticle Formulation, or Ixabepilone With or Without Bevacizumab in Treating Patients With Stage IIIC or Stage IV Breast Cancer
    Bozeman Deaconess Hospital

    Trial Locations
    Bozeman Deaconess Hospital
    Bozeman Deaconess Cancer Center
    Male Breast Cancer, Recurrent Breast Cancer, Stage IIIC Breast Cancer, Stage IV Breast Cancer
    S0720: Adjuvant Therapy Based on Gene Expression in Stage IA and IB Non-Small Cell Lung Cancer
    Bozeman Deaconess Cancer Center
    Bozeman, Montana 59715
    Lung Cancer
    Combination Chemotherapy With or Without Donor Stem Cell Transplant in Treating Patients With Acute Lymphoblastic Leukemia
    Bozeman Deaconess Hospital

    Trial Locations
    Bozeman Deaconess Hospital
    Bozeman Deaconess Cancer Center
    Adult Acute Lymphoblastic Leukemia in Remission, B-cell Adult Acute Lymphoblastic Leukemia, L1 Adult Acute Lymphoblastic Leukemia, L2 Adult Acute Lymphoblastic Leukemia, Philadelphia Chromosome Positive Adult Precursor Acute Lymphoblastic Leukemia, Recurrent Adult Acute Lymphoblastic Leukemia, T-cell Adult Acute Lymphoblastic Leukemia, Untreated Adult Acute Lymphoblastic Leukemia
    Sorafenib and Bevacizumab in Treating Patients With Metastatic Colorectal Cancer
    Bozeman Deaconess Cancer Center
    Bozeman, Montana 59715
    Recurrent Colon Cancer, Recurrent Rectal Cancer, Stage IV Colon Cancer, Stage IV Rectal Cancer
    Topotecan With or Without Aflibercept in Treating Patients With Extensive-Stage Small Cell Lung Cancer
    Bozeman Deaconess Hospital

    Trial Locations
    Bozeman Deaconess Hospital
    Bozeman Deaconess Cancer Center
    Extensive Stage Small Cell Lung Cancer, Recurrent Small Cell Lung Cancer
    Acute Pain Caused by Paclitaxel in Patients With Cancer
    Bozeman Deaconess Cancer Center
    Bozeman, Montana 59715
    Chemotherapeutic Agent Toxicity, Neurotoxicity, Pain, Unspecified Adult Solid Tumor, Protocol Specific
    Paclitaxel With or Without Carboplatin and/or Bevacizumab Followed By Doxorubicin and Cyclophosphamide in Treating Patients With Breast Cancer That Can Be Removed by Surgery
    Bozeman Deaconess Hospital

    Trial Locations
    Bozeman Deaconess Hospital
    Bozeman Deaconess Cancer Center
    Estrogen Receptor-negative Breast Cancer, HER2-negative Breast Cancer, Male Breast Cancer, Progesterone Receptor-negative Breast Cancer, Stage II Breast Cancer, Stage IIIA Breast Cancer, Triple-negative Breast Cancer
    Dasatinib or Placebo, Radiation Therapy, and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
    Bozeman Deaconess Cancer Center
    Bozeman, Montana 59715
    Brain and Central Nervous System Tumors
    S0904: Docetaxel With or Without Vandetanib in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer
    Bozeman Deaconess Cancer Center
    Bozeman, Montana 59715
    Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer